KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 108 filers reported holding KURA ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 11.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,540,000 | -25.2% | 110,000 | 0.0% | 0.05% | -21.0% |
Q3 2021 | $2,060,000 | +9.7% | 110,000 | +22.2% | 0.06% | +8.8% |
Q2 2021 | $1,877,000 | -5.2% | 90,000 | +28.6% | 0.06% | -8.1% |
Q1 2021 | $1,979,000 | -19.2% | 70,000 | -6.7% | 0.06% | -25.3% |
Q4 2020 | $2,450,000 | -20.0% | 75,000 | -25.0% | 0.08% | -34.1% |
Q3 2020 | $3,064,000 | +70.9% | 100,000 | -9.1% | 0.13% | +61.5% |
Q2 2020 | $1,793,000 | +63.7% | 110,000 | 0.0% | 0.08% | +30.0% |
Q1 2020 | $1,095,000 | -11.6% | 110,000 | +22.2% | 0.06% | +15.4% |
Q4 2019 | $1,238,000 | -9.3% | 90,000 | 0.0% | 0.05% | -11.9% |
Q3 2019 | $1,365,000 | -27.0% | 90,000 | -5.3% | 0.06% | -32.2% |
Q2 2019 | $1,871,000 | +7.4% | 95,000 | -9.5% | 0.09% | +8.8% |
Q1 2019 | $1,742,000 | +18.2% | 105,000 | 0.0% | 0.08% | +12.7% |
Q4 2018 | $1,474,000 | +5.3% | 105,000 | +31.2% | 0.07% | +12.7% |
Q3 2018 | $1,400,000 | -3.8% | 80,000 | 0.0% | 0.06% | +8.6% |
Q2 2018 | $1,456,000 | -2.9% | 80,000 | 0.0% | 0.06% | -4.9% |
Q1 2018 | $1,500,000 | +63.4% | 80,000 | +33.3% | 0.06% | +74.3% |
Q4 2017 | $918,000 | +2.3% | 60,000 | 0.0% | 0.04% | +2.9% |
Q3 2017 | $897,000 | – | 60,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |